Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients-Reference-Cited by-同舟云学术

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

Published:2022-05 Issue:5 Volume:22 Page:1467-1474
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Kamar Nassim^ORCID,Abravanel Florence^ORCID,Marion Olivier,Esposito Laure,Hebral Anne Laure,Médrano Chloé,Guitard Joelle,Lavayssière Laurence,Cointault Olivier,Nogier Marie Bétriace,Bellière Julie,Faguer Stanislas^ORCID,Couat Chloé,Del Bello Arnaud^ORCID,Izopet Jacques

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16950

Reference15 articles.

1. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants;Caillard;Kidney Int.,2020

2. Outcomes of COVID-19 in solid organ transplant recipients: a matched cohort study;Pereira;Transpl Infect Dis.,2021

3. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA.,2021

4. Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants;Marion;Ann Intern Med.,2021

5. Occurrence of severe COVID-19 in vaccinated transplant patients;Caillard;Kidney Int.,2021

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “REAl LIfe” observational study on the effectiveness of Evusheld prophylaxis against SARS-CoV-2 omicron variants in vaccine non-responder immunocompromised patients (REALISE);Vaccine;2024-10

2. Comparison of Post-Vaccination Response (Humoral and Cellular) to BNT162b2 in Clinical Cases, Kidney and Pancreas Transplant Recipient with Immunocompetent Subjects over Almost Two Years of Parallel Monitoring;Vaccines;2024-07-26

3. Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis;Kidney Diseases;2024

4. Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy;Journal of Clinical Medicine;2023-11-03

5. Evolution of humoral immune response to SARS-CoV-2 mRNA vaccine in liver transplant recipients – a longitudinal study;Swiss Medical Weekly;2023-10-03